References
- PerouCMSørlieTEisenMBMolecular portraits of human breast tumoursNature2000406679774775210963602
- GruvbergerSRingnérMChenYEstrogen receptor status in breast cancer is associated with remarkably distinct gene expression patternsCancer Res200161165979598411507038
- WestMBlanchetteCDressmanHPredicting the clinical status of human breast cancer by using gene expression profilesProc Natl Acad Sci U S A20019820114621146711562467
- CoatesASWinerEPGoldhirschAPanel MembersTailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Ann Oncol20152681533154625939896
- GruberCJTschugguelWSchneebergerCHuberJCProduction and actions of estrogensN Engl J Med2002346534035211821512
- AndersonLSeilhamerJA comparison of selected mRNA and protein abundances in human liverElectrophoresis1997183-45335379150937
- SerpicoDMolinoLDi CosimoSmicroRNAs in breast cancer development and treatmentCancer Treat Rev201440559560424286642
- MulraneLMcGeeSFGallagherWMO’ConnorDPmiRNA dys-regulation in breast cancerCancer Res201373226554656224204025
- RezaulKThumarJKLundgrenDHDifferential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomicsGenes Cancer20101325127121779449
- KurozumiSYamaguchiYKurosumiMOhiraMMatsumotoHHori-guchiJRecent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypesJ Hum Genet2017621152427439682
- HuCShenSQCuiZHChenZBLiWEffect of microRNA-1 on hepatocellular carcinoma tumor endothelial cellsWorld J Gastroenterol201521195884589226019452
- AlòPLViscaPTrombettaGFatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomasTumori1999851354010228495
- LupuRMenendezJATargeting fatty acid synthase in breast and endo-metrial cancer: An alternative to selective estrogen receptor modulators?Endocrinology200614794056406616809439
- MenendezJALupuRFatty acid synthase (FASN) as a therapeutic target in breast cancerExpert Opin Ther Targets201721111001101628922023
- SørlieTWangYXiaoCDistinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platformsBMC Genomics2006712714116729877
- LiHChenXGuanLMiRNA-181a regulates adipogenesis by targeting tumor necrosis factor-α (TNF-α) in the porcine modelPLoS One2013810e7156824098322
- ShirasakiTHondaMShimakamiTMicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cellsJ Virol20138795270528623449803
- MaoJHZhouRPPengAFmicroRNA-195 suppresses osteosar-coma cell invasion and migration in vitro by targeting FASNOncol Lett2012451125112923162665
- BhatiaHVermaGDattaMmiR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytesBiochim Biophys Acta20141839433434324560669